NeoGenomics, Inc. (NEO)
Company Info
| ISIN | US64049M2098 |
|---|---|
| CUSIP | 64049M209 |
| Sector | Healthcare |
| Industry | Diagnostics & Research |
Highlights
| Market Cap | $1.95B |
|---|---|
| EPS | -$0.66 |
| PEG Ratio | 3.02 |
| Revenue (TTM) | $610.66M |
| Gross Profit (TTM) | $187.90M |
| EBITDA (TTM) | -$20.51M |
| Year Range | $11.03 - $21.22 |
| Target Price | $20.45 |
| Short % | 8.34% |
| Short Ratio | 10.81 |
Share Price Chart
Loading data...
Compare to other instruments
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
Performance Chart
The chart shows the growth of an initial investment of $10,000 in NeoGenomics, Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Returns By Period
NeoGenomics, Inc. had a return of -5.44% year-to-date (YTD) and 5.88% in the last 12 months. Over the past 10 years, NeoGenomics, Inc. had an annualized return of 17.23%, outperforming the S&P 500 benchmark which had an annualized return of 10.64%.
| Period | Return | Benchmark |
|---|---|---|
| Year-To-Date | -5.44% | 7.50% |
| 1 month | 2.89% | -1.61% |
| 6 months | 0.20% | 17.65% |
| 1 year | 5.88% | 26.26% |
| 5 years (annualized) | -8.03% | 11.73% |
| 10 years (annualized) | 17.23% | 10.64% |
Monthly Returns Heatmap
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024 | -8.22% | 5.05% | 0.77% | -11.45% | ||||||||
| 2023 | 13.98% | 29.60% | -10.95% |
Risk-Adjusted Performance
Risk-Adjusted Performance Rank
The current rank of NEO is 51, suggesting that the investment has average results relative to the market in terms of risk-adjusted performance. This ranking is determined by the cumulative values of the indicators listed below.
NeoGenomics, Inc.(NEO)
Risk-Adjusted Performance Indicators
The charts below present risk-adjusted performance metrics for NeoGenomics, Inc. (NEO) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way.
Worst Drawdowns
The table below displays the maximum drawdowns of the NeoGenomics, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the NeoGenomics, Inc. was 99.98%, occurring on Apr 16, 2003. The portfolio has not yet recovered.
The current NeoGenomics, Inc. drawdown is 91.26%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -99.98% | Dec 6, 1999 | 826 | Apr 16, 2003 | — | — | — |
| -44.44% | Nov 11, 1999 | 1 | Nov 11, 1999 | 2 | Nov 16, 1999 | 3 |
| -23.81% | Nov 23, 1999 | 3 | Nov 26, 1999 | 1 | Nov 29, 1999 | 4 |
| -6.25% | Nov 18, 1999 | 1 | Nov 18, 1999 | 1 | Nov 19, 1999 | 2 |
Volatility
Volatility Chart
The current NeoGenomics, Inc. volatility is 16.74%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.
Financials
Financial Performance
Income Statement
| TTM | |
|---|---|
| Revenue | |
Total Revenue | 0.00 |
Cost Of Revenue | 0.00 |
Gross Profit | 0.00 |
| Operating Expenses | |
Selling, General & Admin Expenses | 0.00 |
R&D Expenses | 0.00 |
Total Operating Expenses | 0.00 |
| Income | |
Income Before Tax | 0.00 |
Operating Income | 0.00 |
EBIT | 0.00 |
Earnings From Continuing Operations | 0.00 |
Net Income | 0.00 |
Income Tax Expense | 0.00 |
Interest Expense | 0.00 |
Other Non-Operating Income (Expenses) | 0.00 |
Extraordinary Items | 0.00 |
Discontinued Operations | 0.00 |
Effect Of Accounting Charges | 0.00 |
Non Recurring | 0.00 |
Minority Interest | 0.00 |
Other Items | 0.00 |